Back to rankings
Pelister Keki Sarac & Co

Pelister Keki Sarac & Co

More information

Turkey

3

Commercial, corporate and M&A

The corporate group at Pelister Keki Sarac & Co is especially well-versed in cross-border transactions, regulated industries, and tech-driven businesses. The group has extensive experience advising international clients on Turkish market entry, as well in as advising Turkish companies on outbound investments, and private equity investors engaged in acquisitions and restructurings. Co-leading the team, corporate and finance specialist Kerim Pelister is praised as a ‘a trusted and experienced dealmaker with a strong business mindset’, and Emre Keki, also a corporate and M&A specialist, has additional capabilities in environmental, social and governance matters, as well as green investments.
Legal 500 Editorial commentary

Accolades

Client satisfaction: NPS ®

Testimonials

Collated independently by Legal 500 research team.

  • ‘What makes them unique is: the partners ar accessible and they put a lot of time and effort to the transaction.'
  • ‘Kerim Pelister has a very strong business approach and his strength in contract negotiation is exceptional, as well as his attention to detail.'
  • ‘The collaboration is always seamless, with the team demonstrating excellent legal capability, commercial thinking and always solution-oriented.'
  • ‘Kerim Pelister is a trusted and experienced dealmaker with a strong business mindset.'
  • ‘The team is very internationally minded, knowledgeable, and responsive.'
  • ‘Emre Keki is responsive, has a good mixture of commercial understanding and applicable legal knowledge.'

Key clients

  • Fatro
  • Türkkep
  • Güneşli Aşı
  • Detaysoft
  • MSA
  • Noatum
  • Teknasyon
  • Polsan
  • Ralph Lauren
  • Rebul
  • Vitus
  • Collectürk

Work highlights

Advised Fatro S.p.A. on its acquisition of a 51% stake in Güneşli Aşı İlaç, marking the Italian veterinary pharmaceutical company’s strategic entry into the Turkish market.
Advised a key shareholder of Toksoz Group, in the sale of 35% stake in Sanovel Pharmaceuticals as part of a complex financial restructuring involving multiple group entities.
Advising Ralph Lauren on ongoing corporate governance matters in Turkey, including board and shareholder procedures, regulatory filings, and alignment with the company’s global governance framework.
Practice head

Kerim Pelister; Emre Keki

Other key lawyers

Sertac Kocahal; Ongun Ozel